2010-09-17 |
2010-09-17 |
B
Purchase
|
Garone Michael
Secretary, CFO
Officer
|
60,000
+150.0%
1.08
USD 64,800
|
60,000
+150.0%
|
1.08
|
USD 64,800
|
|
2010-09-17 |
2010-09-15 |
B
Purchase
|
Garone Michael
Secretary, CFO
Officer
|
5,000
+14.3%
1.07
USD 5,350
|
5,000
+14.3%
|
1.07
|
USD 5,350
|
|
2010-09-17 |
2010-09-15 |
B
Purchase
|
Garone Michael
Secretary, CFO
Officer
|
500
+1.4%
1.08
USD 538
|
500
+1.4%
|
1.08
|
USD 538
|
|
2010-09-17 |
2010-09-15 |
B
Purchase
|
Garone Michael
Secretary, CFO
Officer
|
2,500
+7.8%
1.08
USD 2,700
|
2,500
+7.8%
|
1.08
|
USD 2,700
|
|
2010-09-17 |
2010-09-15 |
B
Purchase
|
Garone Michael
Secretary, CFO
Officer
|
32,000
+inf%
1.10
USD 35,200
|
32,000
+inf%
|
1.10
|
USD 35,200
|
|
2009-12-10 |
2009-12-09 |
S
Sale
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Officer
|
7,000
-25.5%
0.70
USD 4,900
|
7,000
-25.5%
|
0.70
|
USD 4,900
|
|
2009-12-10 |
2009-12-09 |
S
Sale
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Officer
|
5,000
-15.4%
0.70
USD 3,500
|
5,000
-15.4%
|
0.70
|
USD 3,500
|
|
2009-12-10 |
2009-12-09 |
S
Sale
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Officer
|
5,000
-13.3%
0.71
USD 3,525
|
5,000
-13.3%
|
0.71
|
USD 3,525
|
|
2009-12-10 |
2009-12-09 |
S
Sale
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Officer
|
5,000
-11.8%
0.72
USD 3,600
|
5,000
-11.8%
|
0.72
|
USD 3,600
|
|
2009-12-10 |
2009-12-09 |
S
Sale
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Officer
|
7,500
-15.0%
0.74
USD 5,550
|
7,500
-15.0%
|
0.74
|
USD 5,550
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
14,744
+41.8%
4.20
USD 61,925
|
14,744
+41.8%
|
4.20
|
USD 61,925
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
200
+0.6%
4.19
USD 838
|
200
+0.6%
|
4.19
|
USD 838
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
100
+0.3%
4.19
USD 419
|
100
+0.3%
|
4.19
|
USD 419
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
100
+0.3%
4.18
USD 418
|
100
+0.3%
|
4.18
|
USD 418
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
737
+2.2%
4.17
USD 3,073
|
737
+2.2%
|
4.17
|
USD 3,073
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
500
+1.5%
4.16
USD 2,080
|
500
+1.5%
|
4.16
|
USD 2,080
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
6,000
+21.7%
4.15
USD 24,900
|
6,000
+21.7%
|
4.15
|
USD 24,900
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
4,400
+18.9%
4.14
USD 18,216
|
4,400
+18.9%
|
4.14
|
USD 18,216
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
300
+1.3%
4.13
USD 1,239
|
300
+1.3%
|
4.13
|
USD 1,239
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
100
+0.4%
4.11
USD 411
|
100
+0.4%
|
4.11
|
USD 411
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
400
+1.8%
4.10
USD 1,640
|
400
+1.8%
|
4.10
|
USD 1,640
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
319
+1.4%
4.09
USD 1,305
|
319
+1.4%
|
4.09
|
USD 1,305
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
200
+0.9%
4.08
USD 816
|
200
+0.9%
|
4.08
|
USD 816
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
300
+1.4%
4.07
USD 1,221
|
300
+1.4%
|
4.07
|
USD 1,221
|
|
2008-08-20 |
2008-08-19 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
1,600
+8.0%
4.06
USD 6,496
|
1,600
+8.0%
|
4.06
|
USD 6,496
|
|
2008-08-20 |
2008-08-18 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
17,781
+801.3%
4.20
USD 74,680
|
17,781
+801.3%
|
4.20
|
USD 74,680
|
|
2008-08-20 |
2008-08-18 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
719
+47.9%
4.19
USD 3,013
|
719
+47.9%
|
4.19
|
USD 3,013
|
|
2008-08-20 |
2008-08-18 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
1,100
+275.0%
4.18
USD 4,598
|
1,100
+275.0%
|
4.18
|
USD 4,598
|
|
2008-08-20 |
2008-08-18 |
B
Purchase
|
Riley Gary
VP, Nonclinical Development
Officer
|
400
+inf%
4.17
USD 1,668
|
400
+inf%
|
4.17
|
USD 1,668
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
1,300
+3.4%
1.69
USD 2,197
|
1,300
+3.4%
|
1.69
|
USD 2,197
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
3,900
+11.2%
1.68
USD 6,552
|
3,900
+11.2%
|
1.68
|
USD 6,552
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
4,700
+15.6%
1.65
USD 7,755
|
4,700
+15.6%
|
1.65
|
USD 7,755
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
2,200
+7.9%
1.60
USD 3,520
|
2,200
+7.9%
|
1.60
|
USD 3,520
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
1,968
+7.6%
1.60
USD 3,149
|
1,968
+7.6%
|
1.60
|
USD 3,149
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
800
+3.2%
1.59
USD 1,272
|
800
+3.2%
|
1.59
|
USD 1,272
|
|
2008-05-13 |
2008-05-09 |
B
Purchase
|
Novinski Michael V
President and CEO
Executive Director
|
132
+0.5%
1.58
USD 209
|
132
+0.5%
|
1.58
|
USD 209
|
|
2007-12-31 |
2007-12-31 |
B
Purchase
|
Novinski Michael V
President and CEO
Officer
|
5,000
+25.0%
2.67
USD 13,336
|
5,000
+25.0%
|
2.67
|
USD 13,336
|
|
2007-08-31 |
2007-08-22 |
B
Purchase
|
GOLDBERG MICHAEL M
Non-Executive Director
|
99,246
0.00
USD 0
|
99,246
|
0.00
|
USD 0
|
|
2007-08-24 |
2007-08-22 |
B
Purchase
|
RACHESKY MARK H MD
Non-Executive Director
Large shareholder
|
129,390
0.00
USD 0
|
129,390
|
0.00
|
USD 0
|
|
2006-05-11 |
2006-05-09 |
B
Purchase
|
RACHESKY MARK H MD
Non-Executive Director
Large shareholder
|
473,577
+inf%
8.26
USD 3,911,746
|
473,577
+inf%
|
8.26
|
USD 3,911,746
|
|
2006-05-11 |
2006-05-09 |
B
Purchase
|
RACHESKY MARK H MD
Non-Executive Director
Large shareholder
|
187,979
+inf%
8.26
USD 1,552,707
|
187,979
+inf%
|
8.26
|
USD 1,552,707
|
|
2006-05-11 |
2006-05-09 |
B
Purchase
|
RACHESKY MARK H MD
Non-Executive Director
Large shareholder
|
31,554
+8.0%
8.26
USD 260,636
|
31,554
+8.0%
|
8.26
|
USD 260,636
|
|
2006-05-11 |
2006-05-09 |
B
Purchase
|
RACHESKY MARK H MD
Non-Executive Director
Large shareholder
|
266,890
+9.3%
8.26
USD 2,204,511
|
266,890
+9.3%
|
8.26
|
USD 2,204,511
|
|
2004-09-21 |
2004-09-16 |
S
Sale
|
BLACK MICHAEL E
Non-Executive Director
|
500
-20.6%
3.61
USD 1,805
|
500
-20.6%
|
3.61
|
USD 1,805
|
|
2004-05-11 |
2004-05-07 |
S
Sale
|
BENDER LEWIS H
Sr. VP Business Development
|
5,000
-26.4%
5.18
USD 25,915
|
5,000
-26.4%
|
5.18
|
USD 25,915
|
|
2004-05-11 |
2004-05-07 |
S
Sale
|
BENDER LEWIS H
Sr. VP Business Development
|
103
-0.7%
5.18
USD 534
|
103
-0.7%
|
5.18
|
USD 534
|
|